Waltham, Massachusetts — October 2, 2025 — Leads & Copy — Moffitt Cancer Center and Evident, which recently acquired Pramana Inc., announced a strategic partnership today. The partnership will leverage the Pramana high-throughput scanning system to support digital adoption across Moffitt’s clinical and research programs.
According to Karen Lu, MD, Executive Vice President and Physician-in-Chief at Moffitt Cancer Center, digital pathology is critical to advancing precision oncology. Integrating Evident’s Pramana systems into Moffitt’s laboratories will enhance efficiency, strengthen diagnostic accuracy, and accelerate progress toward a fully digital environment, ultimately supporting better outcomes for patients.
Moffitt selected the Pramana system for its ability to deliver high-quality images, simplify workflows, and accommodate a wide range of slide types, including cytology and blood smears, within a single platform. The agreement includes the initial acquisition of four scanners, with installation expected to begin later this year.
William Westra, MD, Vice Chair of Pathology at Moffitt Cancer Center, said that Moffitt is committed to adopting technologies that support both clinical care and research innovation. Evident’s Pramana technology will allow Moffitt to process a broader range of slide types, reduce reliance on additional staffing, and lay the groundwork for future integration of AI tools.
Wes Pringle, Evident CEO, said that Evident is proud to work with Moffitt Cancer Center as it advances its digital pathology program. By integrating Pramana systems, Moffitt gains the image quality and operational efficiency needed today, along with a forward-thinking platform designed to support emerging technologies like AI.
Moffitt expects phased implementation over the coming months, with validation and expansion of digital pathology planned as part of its long-term strategy. Full digital adoption is anticipated by 2027.
About EVIDENT
For over 100 years as Olympus, Evident set the industry standard for optical precision in microscopy. Today, as Evident, the company continues to help scientists, physicians, and engineers illuminate the unseen with advanced imaging solutions that combine renowned optics with cutting-edge digital innovation.
Evident is headquartered in Tokyo and supported by R&D and manufacturing centers in Japan, the United States, Germany, and China, with operations and dedicated sales and service centers around the world.
Contact: Michelle Gaynor, michelle.gaynor.ext@evidentscientific.com
